TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $254M (30.9% shares, 69.1% debt)

Holdings (21)

— PDL BIOPHARMA INC 17.2%

Value $43.58M Shares 30,974,000 Est. Cost $1.41 Unrealized —

— MANNKIND CORP 13.3%

Value $33.63M Shares 34,144,000 Est. Cost $0.99 Unrealized —

— OPKO HEALTH INC 12.1%

Value $30.8M Shares 29,500,000 Est. Cost $1.04 Unrealized —

— PACIRA PHARMACEUTICALS INC 10.1%

Value $25.76M Shares 18,500,000 Est. Cost $1.39 Unrealized —

— SALIX PHARMACEUTICALS INC 7.8%

Value $19.84M Shares 300,000 Est. Cost $66.15 Unrealized —

— DENDREON CORP 7.5%

Value $19.09M Shares 26,515,000 Est. Cost $0.72 Unrealized —

— INTERMUNE INC 5.5%

Value $14.07M Shares 17,000,000 Est. Cost $0.83 Unrealized —

— NEKTAR THERAPEUTICS 4.1%

Value $10.52M Shares 911,053 Est. Cost $11.55 Unrealized —

— DEPOMED INC 4.1%

Value $10.35M Shares 1,842,280 Est. Cost $5.62 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 4.0%

Value $10.16M Shares 182,300 Est. Cost $62.32 Unrealized 0.0%

— ONCOGENEX PHARMACEUTICALS INC 3.6%

Value $9.144M Shares 933,100 Est. Cost $9.80 Unrealized —

— MANNKIND CORP 3.0%

Value $7.707M Shares 1,184,784 Est. Cost $6.50 Unrealized —

— ENDOCYTE INC 2.4%

Value $6.115M Shares 465,763 Est. Cost $13.13 Unrealized —

— SAVIENT PHARMACEUTICALS INC 1.8%

Value $4.571M Shares 30,476,000 Est. Cost $0.15 Unrealized —

— CORSICANTO LTD 1.1%

Value $2.722M Shares 2,500,000 Est. Cost $1.09 Unrealized —

— NAVIDEA BIOPHARMACEUTICALS INC 0.9%

Value $2.318M Shares 868,079 Est. Cost $2.67 Unrealized —

— ROCKWELL MEDICAL INC 0.6%

Value $1.618M Shares 448,146 Est. Cost $3.61 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 0.5%

Value $1.253M Shares 10,000,000 Est. Cost $0.13 Unrealized —

— DENDREON CORP 0.1%

Value $328K Shares 79,600 Est. Cost $4.12 Unrealized —

— CYCLACEL PHARMACEUTICALS INC 0.1%

Value $218K Shares 73,895 Est. Cost $2.95 Unrealized —

— AMBIT BIOSCIENCES CORP 0.0%

Value $0 Shares 46 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	PDL BIOPHARMA INC	30,974,000	$43.58M	17.2%	$1.41	—	NOTE 2.875% 2/15/15	69329YAE4
—	MANNKIND CORP	34,144,000	$33.63M	13.3%	$0.99	—	NOTE 3.750% 12/15/13	56400PAA0
—	OPKO HEALTH INC	29,500,000	$30.8M	12.1%	$1.04	—	NOTE 3.0% 2/1/33	68375NAA1
—	PACIRA PHARMACEUTICALS INC	18,500,000	$25.76M	10.1%	$1.39	—	NOTE 3.25% 2/1/19	695127AA8
—	SALIX PHARMACEUTICALS INC	300,000	$19.84M	7.8%	$66.15	—	COM	795435106
—	DENDREON CORP	26,515,000	$19.09M	7.5%	$0.72	—	NOTE 2.875% 1/15/16	24823QAC1
—	INTERMUNE INC	17,000,000	$14.07M	5.5%	$0.83	—	NOTE 2.50% 9/15/18	45884XAE3
—	NEKTAR THERAPEUTICS	911,053	$10.52M	4.1%	$11.55	—	COM	640268108
—	DEPOMED INC	1,842,280	$10.35M	4.1%	$5.62	—	COM	249908104
BMRN	BIOMARIN PHARMACEUTICAL INC	182,300	$10.16M	4.0%	$62.32	0.0%	COM	09061G101
—	ONCOGENEX PHARMACEUTICALS INC	933,100	$9.144M	3.6%	$9.80	—	COM	68230A106
—	MANNKIND CORP	1,184,784	$7.707M	3.0%	$6.50	—	COM	56400P201
—	ENDOCYTE INC	465,763	$6.115M	2.4%	$13.13	—	COM	29269A102
—	SAVIENT PHARMACEUTICALS INC	30,476,000	$4.571M	1.8%	$0.15	—	NOTE 4.750% 2/1/18	80517QAA8
—	CORSICANTO LTD	2,500,000	$2.722M	1.1%	$1.09	—	NOTE 3.50% 1/15/32	220480AC1
—	NAVIDEA BIOPHARMACEUTICALS INC	868,079	$2.318M	0.9%	$2.67	—	COM	63937X103
—	ROCKWELL MEDICAL INC	448,146	$1.618M	0.6%	$3.61	—	COM	774374102
—	SUPERNUS PHARMACEUTICALS INC	10,000,000	$1.253M	0.5%	$0.13	—	NOTE 7.5% 5/1/19	868459AA6
—	DENDREON CORP	79,600	$328K	0.1%	$4.12	—	COM	24823Q107
—	CYCLACEL PHARMACEUTICALS INC	73,895	$218K	0.1%	$2.95	—	COM	23254L306
—	AMBIT BIOSCIENCES CORP	46	$0	0.0%	—	—	COM	02318X100